Évaluation d’un algorithme diagnostique de l’embolie pulmonaire non grave avec successivement : D-Dimères, échodoppler veineux des membres inférieurs et tomodensitométrie hélicoïdale au centre hospitalier d’Annecy

Activating KRAS mutations are found in nearly all cases of pancreatic ductal adenocarcinoma (PDAC), yet effective clinical targeting of oncogenic KRAS remains elusive. Understanding of KRAS-dependent PDAC-promoting pathways could lead to the identifi cation of vulnerabilities and the development of new treatments. We show that oncogenic KRAS induces BNIP3L /NIX expression and a selective mitophagy program that restricts glucose fl ux to the mitochondria and enhances redox capacity. Loss of Nix restores functional mitochondria to cells, increasing demands for NADPH reducing power and decreasing proliferation in glucose-limited conditions. Nix deletion markedly delays progression of pancreatic cancer and improves survival in a murine (KPC) model of PDAC. Although conditional Nix ablation in vivo initially results in the accumulation of mitochondria, mitochondrial content eventually normalizes via increased mitochondrial clearance programs, and pancreatic intraepithelial neoplasia (PanIN) lesions progress to PDAC. We identify the KRAS-NIX mitophagy program as a novel driver of glycolysis, redox robustness, and disease progression in PDAC. SIGNIFICANCE: NIX-mediated mitophagy is a new oncogenic KRAS effector pathway that suppresses functional mitochondrial content to stimulate cell proliferation and augment redox homeostasis. This pathway promotes the progression of PanIN to PDAC and represents a new dependency in pancreatic cancer.

show abstract

Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer

Humpton

et al. 2019

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Évaluation d’un algorithme diagnostique de l’embolie pulmonaire non grave avec successivement : D-Dimères, échodoppler veineux des membres inférieurs et tomodensitométrie hélicoïdale au centre hospitalier d’Annecy

Cited by 1 publication

References 13 publications

Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer

Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer

Contact Info

Product

Resources

About